Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasm, Residual × Prednisone × Clear all

Sponsor

Conditions

Prostatic Neoplasms 101 Lymphoma 56 Lymphoma, Large B-Cell, Diffuse 44 Precursor Cell Lymphoblastic Leukemia-Lymphoma 28 Lymphoma, Non-Hodgkin 27 Burkitt Lymphoma 21 Lymphoma, Follicular 20 Multiple Myeloma 17 Neoplasms 13 Neoplasm Metastasis 13 Leukemia 13 Hodgkin Disease 13 Lymphoma, Large-Cell, Anaplastic 11 Lymphoma, B-Cell 11 Lymphoma, Mantle-Cell 10 Lymphoma, B-Cell, Marginal Zone 8 Lymphoma, T-Cell, Peripheral 7 Lymphoma, T-Cell 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Large-Cell, Immunoblastic 4 Immunoblastic Lymphadenopathy 4 Waldenstrom Macroglobulinemia 3 Recurrence 3 Prostate Cancer Metastatic 3 Primary Myelofibrosis 3 Plasmablastic Lymphoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Pain 3 Myelodysplastic Syndromes 3 Lymphoma, AIDS-Related 3

Interventions

Rituximab 4 blinatumomab 3 Whole-Body Irradiation 2 Lenalidomide 2 Cyclophosphamide 2 Clofarabine 2 treosulfan 1 thymoglobulin 1 sabatolimab 1 peginterferon alfa-2a 1 obinutuzumab 1 midostaurin 1 ixazomib 1 fludarabine phosphate 1 fludarabine 1 eribulin 1 daratumumab 1 acalabrutinib 1 Trastuzumab 1 Tacrolimus 1 Sodium Chloride 1 Peripheral Blood Stem Cell Transplantation 1 Pentostatin 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Magnetic Resonance Imaging 1 Imatinib Mesylate 1 Histamine Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡